Antares Pharma, Inc. has reported positive results from a multi-centre phase II clinical study evaluating the pharmacokinetic profile of testosterone enanthate administered once-weekly by subcutaneous ...

Antares Pharma, Inc., a leading developer and marketer of parenteral pharmaceuticals, has dosed its first patient in a clinical study evaluating testosterone enanthate administered weekly by ...

Certain health conditions can make it difficult for some men to have normal levels of testosterone. Low testosterone levels, also known as hypogonadism, can affect a person’s life, can cause different ...

The auto injector market represents a rapidly expanding segment within the global pharmaceutical delivery systems industry, driven by the increasing prevalence of chronic diseases and the growing ...